Patent classifications
C
C07
C07F
9/00
C07F9/02
C07F9/06
C07F9/22
C07F9/24
C07F9/2454
C07F9/2479
C07F9/2479
NUCLEOSIDE PHOSPHORAMIDATES
20250057867
·
2025-02-20
·
Disclosed herein are nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful as inhibitors of HCV NS5B polymerase, as inhibitors of HCV replication and for treatment of hepatitis C infection in mammals.